TIM-3 Alzheimer’s therapy is emerging as a groundbreaking approach to tackling one of the most challenging aspects of Alzheimer’s disease treatment.Recent research has revealed that TIM-3, an immune checkpoint molecule, plays a pivotal role in hindering the action of microglia, the brain’s immune cells, from effectively clearing amyloid plaques associated with cognitive decline.